Related Experiment Video
Updated: Jun 22, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Rivaroxaban's vascular dose for the neurovascular clinician
1Stroke Center, New York Medical College, Westchester Medical Center, Valhalla, NY, USA.
Rivaroxaban effectively treats vascular conditions and prevents strokes in atrial fibrillation. A low dose combined with aspirin reduces cardiovascular events and may prevent strokes in high-risk non-atrial fibrillation patients.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Rivaroxaban is an effective direct oral anticoagulant for vascular conditions.
- It is proven for venous thromboembolism treatment and stroke prevention in non-valvular atrial fibrillation.
Discussion:
- A very low dose of rivaroxaban with low-dose aspirin reduces major adverse cardiovascular events, including stroke.
- This combination shows promise in acute and chronic coronary syndrome.
Key Insights:
- The combination therapy is a potential strategy for stroke prevention.
- It targets selected non-atrial fibrillation patients at high risk of stroke.
Outlook:
- Further research may establish this combination as a standard of care.
- This approach could expand therapeutic options for cardiovascular risk reduction.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Vascular Spasm
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...